Rosemont Group

Rosemont Pharmaceuticals is a leading UK-based specialty pharmaceutical company dedicated to the development and manufacture of oral liquid medicines. Founded in 1967 and headquartered in Leeds, the company specializes in providing liquid alternatives for patients who have difficulty swallowing solid dosage forms, such as tablets or capsules. Their extensive portfolio comprises over 130 oral liquid products across various therapeutic categories, including cardiovascular, central nervous system, and endocrinology. Rosemont is recognized for its expertise in liquid formulation technology and operates a state-of-the-art, MHRA-approved manufacturing facility. The company serves a critical role in the healthcare sector by improving medication adherence and safety for geriatric and pediatric populations.